Irena Marková

40th EASD Annual Meeting of the European Association for the Study of Diabetes

M. Veitenhansl, K. Stegner, F. X. Hierl et al. · Diabetologia · 2004 · 68 citations · Full text

Medicine, Endocrinology, Diabetology +11

In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia

Martina Hüttl, Irena Marková, Denisa Miklánková et al. · International Journal of Molecular Sciences · 2021 · 46 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Increased expression and altered subcellular distribution of PKC-δ in chronically hypoxic rat myocardium: involvement in cardioprotection

Jan Neckář, Irena Marková, František Novák et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2004 · 45 citations

Medicine, Biochemistry, Physiology +16

Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model

Denisa Miklánková, Irena Marková, Martina Hüttl et al. · International Journal of Molecular Sciences · 2021 · 42 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Complex Positive Effects of SGLT-2 Inhibitor Empagliflozin in the Liver, Kidney and Adipose Tissue of Hereditary Hypertriglyceridemic Rats: Possible Contribution of Attenuation of Cell Senescence and Oxidative Stress

Jaroslava Trnovská, Petr Svoboda, Helena Pelantová et al. · International Journal of Molecular Sciences · 2021 · 36 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17